UNLABELLED: BACKGROUND - RATIONALE FOR STUDY: Atrial fibrillation is associated with an increased risk of stroke and mortality which is reduced by treatment with warfarin. The most commonly used tool to assess the effectiveness of warfarin therapy is the time in therapeutic range (TTR) of International Normalised Ratio (INR) 2.0-3.0. Our aim was to study whether INR variability, as assessed by the standard deviation of transformed INR (SDT(INR)) is more prognostically important than the TTR. METHODS AND RESULTS: We studied 19,180 patients with atrial fibrillation on warfarin therapy to evaluate the association of TTR and that of SDT(INR) with all-cause mortality, stroke, bleeding and hospitalisation. The SDT(INR) was more prognostically important than the TTR. One standard deviation (SD) higher of SDT(INR) had a hazard ratio (HR) of 1.59 (95% CI 1.52-1.66) of mortality compared with 1.18 (95% CI 1.13-1.24) for one SD lower of TTR. For the other 3 events the HR was also higher for the SDT(INR) than for the TTR (stroke 1.30 (95% CI 1.22-1.39) vs. 1.06 (95% CI 1.00-1.13), bleeding 1.27 (95% CI 1.20-1.35) vs. 1.07 (95% CI 1.01-1.14) , hospitalisation 1.47 (95% CI 1.45-1.49) vs. 1.13 (95% CI 1.10-1.15). When both metrics were included in the same analysis only the SDT(INR) was of significant predictive value. CONCLUSIONS: The SDT(INR) is a better predictor of mortality, stroke, bleeding and hospitalisation than the TTR in patients with atrial fibrillation receiving warfarin therapy.
UNLABELLED: BACKGROUND - RATIONALE FOR STUDY: Atrial fibrillation is associated with an increased risk of stroke and mortality which is reduced by treatment with warfarin. The most commonly used tool to assess the effectiveness of warfarin therapy is the time in therapeutic range (TTR) of International Normalised Ratio (INR) 2.0-3.0. Our aim was to study whether INR variability, as assessed by the standard deviation of transformed INR (SDT(INR)) is more prognostically important than the TTR. METHODS AND RESULTS: We studied 19,180 patients with atrial fibrillation on warfarin therapy to evaluate the association of TTR and that of SDT(INR) with all-cause mortality, stroke, bleeding and hospitalisation. The SDT(INR) was more prognostically important than the TTR. One standard deviation (SD) higher of SDT(INR) had a hazard ratio (HR) of 1.59 (95% CI 1.52-1.66) of mortality compared with 1.18 (95% CI 1.13-1.24) for one SD lower of TTR. For the other 3 events the HR was also higher for the SDT(INR) than for the TTR (stroke 1.30 (95% CI 1.22-1.39) vs. 1.06 (95% CI 1.00-1.13), bleeding 1.27 (95% CI 1.20-1.35) vs. 1.07 (95% CI 1.01-1.14) , hospitalisation 1.47 (95% CI 1.45-1.49) vs. 1.13 (95% CI 1.10-1.15). When both metrics were included in the same analysis only the SDT(INR) was of significant predictive value. CONCLUSIONS: The SDT(INR) is a better predictor of mortality, stroke, bleeding and hospitalisation than the TTR in patients with atrial fibrillation receiving warfarin therapy.
Authors: Otito F Iwuchukwu; Andrea H Ramirez; Yaping Shi; Erica A Bowton; Vivian K Kawai; Jonathan S Schildcrout; Dan M Roden; Joshua C Denny; C Michael Stein Journal: Pharmacogenet Genomics Date: 2016-11 Impact factor: 2.089
Authors: Scott Davis; Jane Gralla; Patrick Klem; Suhong Tong; Gina Wedermyer; Brian Freed; Alexander Wiseman; James E Cooper Journal: Am J Transplant Date: 2017-10-24 Impact factor: 8.086
Authors: Lauren V Huckaby; Laura M Seese; Thomas G Gleason; Ibrahim Sultan; Yisi Wang; Floyd Thoma; Arman Kilic Journal: J Thorac Dis Date: 2021-05 Impact factor: 2.895